1-11 of 11
Neil Sebire
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma

Open Access
Laura Privitera, Dale J. Waterhouse, Alessandra Preziosi, Irene Paraboschi, Olumide Ogunlade, Chiara Da Pieve, Marta Barisa, Olumide Ogunbiyi, Gregory Weitsman, J. Ciaran Hutchinson, Kate Cross, Lorenzo Biassoni, Danail Stoyanov, Neil Sebire, Paul Beard, Paolo De Coppi, Gabriela Kramer-Marek, John Anderson, Stefano Giuliani
Journal: Cancer Research
Cancer Res (2023) 83 (12): 2077–2089.
https://doi.org/10.1158/0008-5472.CAN-22-2918
Published: 15 June 2023
View article titled, Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
Open the PDF for Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma in another window
Includes: Multimedia, Supplementary data
Journal Articles

Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma

Free
Konstantinos Zormpas-Petridis, Evon Poon, Matthew Clarke, Neil P. Jerome, Jessica K.R. Boult, Matthew D. Blackledge, Fernando Carceller, Alexander Koers, Giuseppe Barone, Andrew D.J. Pearson, Lucas Moreno, John Anderson, Neil Sebire, Kieran McHugh, Dow-Mu Koh, Louis Chesler, Yinyin Yuan, Simon P. Robinson, Yann Jamin
Journal: Cancer Research
Series: Author Choice
Cancer Res (2020) 80 (16): 3424–3435.
https://doi.org/10.1158/0008-5472.CAN-20-0133
Published: 14 August 2020
View article titled, Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma
Open the PDF for Noninvasive MRI Native T1 Mapping Detects Response to MYCN-targeted Therapies in the Th-MYCN Model of Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis

Free
Orli Yogev, Gilberto S. Almeida, Karen T. Barker, Sally L. George, Colin Kwok, James Campbell, Magdalena Zarowiecki, Dimitrios Kleftogiannis, Laura M. Smith, Albert Hallsworth, Philip Berry, Till Möcklinghoff, Hannah T. Webber, Laura S. Danielson, Bliss Buttery, Elizabeth A. Calton, Barbara M. da Costa, Evon Poon, Yann Jamin, Stefano Lise, Gareth J. Veal, Neil Sebire, Simon P. Robinson, John Anderson, Louis Chesler
Journal: Cancer Research
Cancer Res (2019) 79 (20): 5382–5393.
https://doi.org/10.1158/0008-5472.CAN-18-2759
Published: 15 October 2019
View article titled, In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis
Open the PDF for In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis in another window
Includes: Supplementary data
Journal Articles

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment

Free
Konstantinos Zormpas-Petridis, Neil P. Jerome, Matthew D. Blackledge, Fernando Carceller, Evon Poon, Matthew Clarke, Ciara M. McErlean, Giuseppe Barone, Alexander Koers, Sucheta J. Vaidya, Lynley V. Marshall, Andrew D.J. Pearson, Lucas Moreno, John Anderson, Neil Sebire, Kieran McHugh, Dow-Mu Koh, Yinyin Yuan, Louis Chesler, Simon P. Robinson, Yann Jamin
Journal: Cancer Research
Series: Author Choice
Cancer Res (2019) 79 (11): 2978–2991.
https://doi.org/10.1158/0008-5472.CAN-18-3412
Published: 03 June 2019
View article titled, MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment
Open the PDF for MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Antiangiogenic Treatment in another window
Includes: Supplementary data
Journal Articles

Abstract A1-67: Prognostic significance of copy number aberrations in Wilms tumor

Free
Tasnim Chagtai, Christina Zill, Linda Dainese, Jenny Wegert, Mariana Maschietto, Gordan Vujanic, Neil Sebire, Ivo Leuschner, Peter Ambros, Maureen O'Sullivan, Christophe Bergeron, David Gisselsson, Marcel Kool, Marry van den Heuvel-Eibrink, Norbert Graf, Harm van Tinteren, Aurore Coulomb, Manfred Gessler, Richard Williams, Kathy Pritchard-Jones
Journal: Cancer Research
Cancer Res (2015) 75 (22_Supplement_1): A1-67.
https://doi.org/10.1158/1538-7445.TRANSCAGEN-A1-67
Published: 15 November 2015
View article titled, Abstract A1-67: Prognostic significance of copy number aberrations in Wilms tumor
Journal Articles

Abstract LB-328: SHP-1, p53 and Y674/Y675-phosphorylated-trkA: a molecular pathway and prognostic marker for neuroblastoma

Free
Gehad Youssef, Cheryl Gillet, Dyanne Rampling, Mirza Chagtay, Alex Virasami, Neil Sebire, John Anderson, Ximena Montano
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): LB-328.
https://doi.org/10.1158/1538-7445.AM2014-LB-328
Published: 01 October 2014
View article titled, Abstract LB-328: SHP-1, p53 and Y674/Y675-phosphorylated-trkA: a molecular pathway and prognostic marker for neuroblastoma
Journal Articles

Abstract B36: DNA methylation profiling describes Wilms tumor evolution from its precursor lesion

Free
Jocelyn Charlton, Richard Williams, Marisa Alcaide-German, Neil Sebire, Sergey Popov, Kathy Pritchard-Jones, Stephan Beck
Journal: Cancer Research
Cancer Res (2013) 73 (13_Supplement): B36.
https://doi.org/10.1158/1538-7445.CEC13-B36
Published: 13 May 2014
View article titled, Abstract B36: DNA methylation profiling describes Wilms tumor evolution from its precursor lesion
Journal Articles

Abstract 3829: TP53 mutation status defines two distinct classes of diffuse anaplastic Wilms tumor.

Free
Mariana Maschietto, Tasnim Chagtai, Sergey D. Popov, Neil Sebire, Gordan Vujanic, Sandra Hing, Paul Grundy, Jeffrey S. Dome, Kathy Pritchard-Jones, Richard D. Williams
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 3829.
https://doi.org/10.1158/1538-7445.AM2013-3829
Published: 15 April 2013
View article titled, Abstract 3829: TP53 mutation status defines two distinct classes of diffuse anaplastic Wilms tumor.
Journal Articles

Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy

Free
Mengyong Yan, Nourredine Himoudi, Martin Pule, Neil Sebire, Edmund Poon, Allison Blair, Owen Williams, John Anderson
Journal: Cancer Research
Cancer Res (2008) 68 (19): 8058–8065.
https://doi.org/10.1158/0008-5472.CAN-08-0153
Published: 30 September 2008
View article titled, Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy
Open the PDF for Development of Cellular Immune Responses against PAX5, a Novel Target for Cancer Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Hyperplastic/proliferating perilobar nephrogenic rests are molecular genetic precursor lesions of Wilms tumor

Free
Raisa Vuononvirta, Jorge Reis-Filho, Neil Sebire, Alan Mackay, Kerry Fenwick, Alan Ashworth, Kathy Pritchard-Jones, Gordan Vujanic, Chris Jones
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2941.
Published: 01 May 2007
View article titled, Hyperplastic/proliferating perilobar nephrogenic rests are molecular genetic precursor lesions of Wilms tumor
Journal Articles

A novel complex comprising BRaf, PKCϵ and S6K2 mediates the pro-survival effects of FGF-2 in small cell lung cancer cells

Free
Michael Seckl, Olivier Pardo, Neil Sebire, Frances Bowen, Ivan Gout, Richard Marias, Julian Downward
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2522.
Published: 01 May 2007
View article titled, A novel complex comprising BRaf, PKCϵ and S6K2 mediates the pro-survival effects of FGF-2 in small cell lung cancer cells